The Serum Institute of India has donated the vaccines enabling the conduct of the IMVACS clinical trial and is also the sponsor of its ancillary study, the SAFLI-R21-10.From June 1–4th, 2025, Professor Halidou Tinto visited the Serum Institute of India in Pune, further strengthening collaboration with this group of researchers.